TY - JOUR
T1 - Targets for the reduction of antibiotic use in humans in the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) partner countries
AU - European Survey on Transatlantic Task Force on Antimicrobial Resistance (TATFAR)
AU - D’Atri, Fabio
AU - Arthur, Jacqueline
AU - Blix, Hege Salvesen
AU - Hicks, Lauri A.
AU - Plachouras, Diamantis
AU - Monnet, Dominique L.
AU - Strauß, Reinhild
AU - Ingenbleek, Anne
AU - Christova, Iva
AU - Andrašević, Arjana Tambić
AU - Žemličkova, Helena
AU - Moloney, Christina
AU - Märtin, Pille
AU - Jalava, Jari
AU - Cavalié, Philippe
AU - Eckmanns, Tim
AU - Kontopidou, Flora
AU - Matuz, Maria
AU - Gudnason, Thorolfur
AU - Burns, Karen
AU - Iannazzo, Stefania
AU - Nikiforova, Raina
AU - Valintėlienė, Rolanda
AU - Guérin, Valérie
AU - Borg, Michael A.
AU - de Greeff, Sabine
AU - Steinbakk, Martin
AU - Olczak-Pieńkowska, Anna
AU - Serban, Roxana
AU - Schreterova, Eva
AU - Čižman, Milan
AU - Navas, Antonio López
AU - Ståhlgren, Gunilla Skoog
AU - Johnson, Alan
AU - Reilly, Jacqui
N1 - Publisher Copyright:
© 2019 European Centre for Disease Prevention and Control (ECDC). All rights reserved.
PY - 2019/7/11
Y1 - 2019/7/11
N2 - Unnecessary and inappropriate use of antibiotics in human healthcare is a major driver for the development and spread of antimicrobial resistance; many countries are implementing measures to limit the overuse and misuse of antibiotics e.g. through the establishment of antimicrobial use reduction targets. We performed a review of antimicrobial use reduction goals in human medicine in Transatlantic Taskforce on Antimicrobial Resistance partner countries. On 31 March 2017, the European Centre for Disease Prevention and Control sent a questionnaire to National Focal Points for Antimicrobial Consumption and the National Focal Points for Antimicrobial Resistance in 28 European Union countries, Iceland and Norway. The same questionnaire was sent to the TATFAR implementers in Canada and the United States. Thirty of 32 countries replied. Only nine countries indicated that they have established targets to reduce antimicrobial use in humans. Twenty-one countries replied that no target had been established. However, 17 of these 21 countries indicated that work to establish such targets is currently underway, often in the context of developing a national action plan against antimicrobial resistance. The reported targets varied greatly between countries and can be a useful resource for countries willing to engage in the reduction of antibiotic use in humans.
AB - Unnecessary and inappropriate use of antibiotics in human healthcare is a major driver for the development and spread of antimicrobial resistance; many countries are implementing measures to limit the overuse and misuse of antibiotics e.g. through the establishment of antimicrobial use reduction targets. We performed a review of antimicrobial use reduction goals in human medicine in Transatlantic Taskforce on Antimicrobial Resistance partner countries. On 31 March 2017, the European Centre for Disease Prevention and Control sent a questionnaire to National Focal Points for Antimicrobial Consumption and the National Focal Points for Antimicrobial Resistance in 28 European Union countries, Iceland and Norway. The same questionnaire was sent to the TATFAR implementers in Canada and the United States. Thirty of 32 countries replied. Only nine countries indicated that they have established targets to reduce antimicrobial use in humans. Twenty-one countries replied that no target had been established. However, 17 of these 21 countries indicated that work to establish such targets is currently underway, often in the context of developing a national action plan against antimicrobial resistance. The reported targets varied greatly between countries and can be a useful resource for countries willing to engage in the reduction of antibiotic use in humans.
UR - http://www.scopus.com/inward/record.url?scp=85070021194&partnerID=8YFLogxK
U2 - 10.2807/1560-7917.ES.2019.24.28.1800339
DO - 10.2807/1560-7917.ES.2019.24.28.1800339
M3 - Review article
C2 - 31311620
AN - SCOPUS:85070021194
SN - 1025-496X
VL - 24
JO - Eurosurveillance
JF - Eurosurveillance
IS - 28
M1 - 1800339
ER -